| RS2536888088 |
TRPS1
|
Health Risk |
Likely pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS2536888237 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536888411 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2536888603 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536888816 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536890328 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536890438 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS2536890739 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536890849 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS2536891347 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536891407 |
TRPS1
|
Health Risk |
Likely pathogenic |
TRPS1-related disorder, TRPS1-related disorder |
| RS2536891736 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536893785 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS2536894969 |
GRHL2
|
Health Risk |
Likely pathogenic |
GRHL2-related disorder, GRHL2-related disorder |
| RS2536894997 |
GRHL2
|
Health Risk |
Pathogenic |
— |
| RS2536896446 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536896644 |
TMEM67
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536896797 |
TMEM67
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536899211 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2536903110 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536904331 |
TMEM67
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536904460 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536912033 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536912345 |
TMEM67
|
Health Risk |
Pathogenic |
Joubert syndrome 6, Joubert syndrome 6 |
| RS2536913760 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS2536914014 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536914279 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS2536914781 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536915201 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536916470 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS2536921416 |
KCNQ3
|
Health Risk |
Likely pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS2536923923 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2536926049 |
SBDS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2536926716 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536928013 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Shwachman-Diamond syndrome 1 |
| RS2536928420 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536928737 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2536929338 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536929958 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome and related disorders, Meckel-Gruber syndrome |
| RS2536930168 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2536930205 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2536930338 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536932319 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2536932390 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2536932418 |
SBDS
|
Health Risk |
Pathogenic |
Aplastic anemia, Shwachman-Diamond syndrome 1 |
| RS2536932431 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Shwachman-Diamond syndrome 1 |
| RS2536941528 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Benign neonatal seizures |
| RS2536943817 |
KCNQ3
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2536943945 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS2536947549 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536947667 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536947862 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536948872 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2536952207 |
KCNQ3
|
Health Risk |
Likely pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS2536952593 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS2536957931 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536957939 |
CSNK2B
|
Health Risk |
Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536958296 |
LY6G5B
|
Health Risk |
Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536958403 |
CSNK2B
|
Health Risk |
Pathogenic/Likely pathogenic |
CSNK2B-related disorder, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536962628 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536962966 |
GRHL2
|
Health Risk |
Likely pathogenic |
— |
| RS2536963135 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536963193 |
CSNK2B
|
Health Risk |
Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536965692 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2536966052 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536966071 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536966124 |
CSNK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Poirier-Bienvenu neurodevelopmental syndrome, Inborn genetic diseases |
| RS2536967534 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS2536967665 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536967921 |
CSNK2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Inborn genetic diseases |
| RS2536968042 |
CSNK2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2536968043 |
TMEM67
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2536970927 |
CSNK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536971072 |
CSNK2B
|
Health Risk |
Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS2536972468 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2536972479 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2536973791 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2537009025 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2537009990 |
EYA1
|
Health Risk |
Likely pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |
| RS2537010153 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2537010834 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |
| RS2537011164 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2537012229 |
EYA1
|
Health Risk |
Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537012799 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2537013005 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2537013459 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2537014883 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2537017106 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537017451 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537018716 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537019323 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537020226 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537032583 |
EZH2
|
Health Risk |
Likely pathogenic |
EZH2-related disorder, EZH2-related disorder |
| RS2537038799 |
DST
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2537060641 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 1, Branchiootic syndrome 1 |
| RS2537075380 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2537101266 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537101394 |
DST
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Epidermolysis bullosa simplex 3 |
| RS2537101947 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537130353 |
WDR91
|
Health Risk |
Pathogenic |
— |